Walleye Trading
COGT icon

Walleye Trading’s Cogent Biosciences COGT Stock Holding History

Walleye Trading’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-38,652
Closed -$377K – 5114
2023
Q3 		$377K Buy
38,652
+15,007
+63% +$178K ﹤0.01% 3194
2023
Q2 		$280K Sell
23,645
-22,477
-49% -$258K ﹤0.01% 3204
2023
Q1 		$498K Buy
46,122
+20,268
+78% +$259K ﹤0.01% 2804
2022
Q4 		$299K Buy
+25,854
New +$320K ﹤0.01% 3246
2019
Q1 		– Sell
-16,371
Closed -$288K – 4269
2018
Q4 		$288K Buy
+16,371
New +$484K ﹤0.01% 3017

Other funds holding COGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's COGT Position: Q4 2023 in Review

Walleye Trading sold out of Cogent Biosciences (COGT) in Q4 2023, closing a stake of 38,652 shares — an estimated $377K sold.

Walleye Trading first reported a position in COGT in Q4 2018 and held it in 5 quarters. The position peaked at $498K in Q1 2023. 144 funds tracked by Wall St. Rank hold COGT as of Q4 2023.

  • Walleye Trading reported no remaining Cogent Biosciences position as of Q4 2023 after selling out during the quarter.
  • Walleye Trading sold 38,652 Cogent Biosciences shares in Q4 2023, an estimated $377K.
  • Walleye Trading first reported a position in Cogent Biosciences in Q4 2018 and held it in 5 quarters.
  • Walleye Trading's Cogent Biosciences position peaked at $498K in Q1 2023.
  • 144 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.